Cytoreductive Surgery may be beneficial for highly selected patients with Metastatic Gastrointestinal Stromal Tumors receiving Regorafenib facing Local Progression: A Case Controlled Study

Conclusions: Cytoreductive surgery might be feasible in highly selected patients with pre-treated GIST who are being treated with regorafenib experiencing LP.

Source: Journal of Cancer - April 19, 2021 Category: Cancer & Oncology Authors: Chun-Nan Yeh, Chia-Hsiang Hu, Shang-Yu Wang, Chiao-En Wu, Jen-Shi Chen, Chun-Yi Tsai, Jun-Te Hsu, Ta-Sen Yeh Tags: Research Paper Source Type: research